Director
CurrentDirector/Clinical Research Consultant Feb 2012 - current Set up a consultancy practice providing clinical research services to pharmaceutical and biotech companies across all aspects of drug/device development, from study start up to close out, and across a broad range of therapeutic areas. • Australian Government - Infectious Disease Prophylaxis study• Global Pharmaceutical Company Client – Quality Oversight for Oncology study• Local Biotech… Show more Director/Clinical Research Consultant Feb 2012 - current Set up a consultancy practice providing clinical research services to pharmaceutical and biotech companies across all aspects of drug/device development, from study start up to close out, and across a broad range of therapeutic areas. • Australian Government - Infectious Disease Prophylaxis study• Global Pharmaceutical Company Client – Quality Oversight for Oncology study• Local Biotech Company Client – Phase 2 Oncology study• International CRO – Community Engagement Project• Local Biotech Company Client – Phase 1 Oncology Diagnostic Imaging study• Global Pharmaceutical Company Client – regulatory support for observational study• Local Biotech Company Client – Phase 1 Oncology study• Local Biotech Company Client - Phase 2a Pain study• Global CRO Client - Phase 3 Autoimmune Disease study• Global Biotech Company Client – Phase 1 Oncology study• Local Biotech Company Client - Phase 2b osteoarthritis study• Local Biotech Company Client – coordination of Special Access Scheme• Local Biotech Company Client - Phase 2 Rheumatology study• Global Pharmaceutical Company Client - Phase 2 Hepatic study • Local Biotech Company Client - Phase 1 Orthopaedic study• Local Biotech Company Client - Phase 1 Respiratory Study• Global Medical Device Company - Phase 3 Type 2 Diabetes Device study• Local Device Company Client - Phase 1 surgical device study• Global Pharmaceutical Company Client - File checks/audit for study transfer preparation.• Global CRO Client - Phase 3 psychiatry study, Phase 2 paediatric hepatic study, 6 x cardiac device studies.• Local Biotech Company Client - Phase 2 renal study. • Local Biotech Company Client - Phase 2 paediatric parasite study. • Global Pharmaceutical Company Client - Phase 2 oncology study, Phase 3 oncology study, Phase 3 Rheumatoid Arthritis study, Non-Interventional neuroscience study. Show less